1. Home
  2. CRDF vs VNCE Comparison

CRDF vs VNCE Comparison

Compare CRDF & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$1.36

Market Cap

86.8M

Sector

Health Care

ML Signal

HOLD

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$9.91

Market Cap

82.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDF
VNCE
Founded
1999
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
86.8M
82.0M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
CRDF
VNCE
Price
$1.36
$9.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$9.63
$5.17
AVG Volume (30 Days)
870.9K
402.7K
Earning Date
05-07-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
27.37
132.45
EPS
N/A
0.65
Revenue
$365,993.00
$300,007,000.00
Revenue This Year
N/A
$5.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$15.11
Revenue Growth
49.61
2.23
52 Week Low
$0.76
$1.95
52 Week High
$3.31
$9.99

Technical Indicators

Market Signals
Indicator
CRDF
VNCE
Relative Strength Index (RSI) 68.98 71.40
Support Level $1.18 $5.63
Resistance Level $1.43 N/A
Average True Range (ATR) 0.09 0.83
MACD 0.03 0.39
Stochastic Oscillator 70.12 96.85

Price Performance

Historical Comparison
CRDF
VNCE

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale and Vince Direct-to-consumer. It operates its e-commerce business through its website. Maximum of its revenue generated from Vince Wholesale segment.

Share on Social Networks: